Metraipolis › archive › dc_b296405ebc57
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41053095
- DOI
- 10.1038/s41420-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:08:05.403Z
- SHA-256 of the archived text
28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca- Stable URL of this page
https://metraipolis.com/documento/dc_b296405ebc57
How to cite
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095 — Europe PMC (en), https://europepmc.org/article/MED/41053095 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b296405ebc57 (Metraipolis archive dc_b296405ebc57, sha256 28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca)
BibTeX
@misc{dcb296405ebc57,
title = {BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41053095},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b296405ebc57; sha256 28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053095. Agents can read the archived copy with the MCP tool read_document.